Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study.

Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study.

There is no licensed treatment for non-alcoholic fatty liver disease (NAFLD), a condition that increases risk of chronic liver disease, type 2 diabetes and cardiovascular disease. We tested whether 15-18 months treatment with docosahexaenoic acid (DHA) plus eicosapentaenoic acid (EPA) (Omacor/Lovaza...

Full description

Bibliographic Details
Main Authors:	Scorletti, E, Bhatia, L, McCormick, K, Clough, G, Nash, K, Hodson, L, Moyses, H, Calder, P, Byrne, C
Format:	Journal article
Language:	English
Published:	2014

Similar Items

Potential benefits of purified long chain omega-3 fatty acid treatment in non-alcoholic fatty liver disease (NAFLD): a potential treatment for early NAFLD in metabolic syndrome and Type 2 diabetes? Results from the WELCOME study
by: Scorletti, E, et al.
Published: (2014)

Whole-body and hepatic dietary fatty acid oxidation is related to postprandial insulin concentrations in people with non-alcoholic fatty liver disease with varying degrees of insulin resistance
by: Hodson, L, et al.
Published: (2013)

Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study
by: Hodson, L, et al.
Published: (2017)

Distinguishing Health Benefits of Eicosapentaenoic and Docosahexaenoic Acids
by: Fraser D. Russell, et al.
Published: (2012-11-01)

Comparison and validation of a fast method for the extraction and quantification of α-linolenic, eicosapentaenoic, and docosahexaenoic fatty acids
by: Alejandro OVIEDO CASTRILLÓN, et al.
Published: (2016-12-01)

Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.
by: Noriko Suzuki-Kemuriyama, et al.
Published: (2016-01-01)

Eicosapentaenoic acid and docosahexaenoic acid suppress colonic tumorigenesis in obese mice
by: Yan Xu, et al.
Published: (2024-05-01)

Fatty Acid Taste Receptor GPR120 Activation by Arachidonic Acid, Eicosapentaenoic Acid, and Docosahexaenoic Acid in Chickens
by: Fuminori Kawabata, et al.
Published: (2022-07-01)

Dietary Docosahexaenoic Acid and Eicosapentaenoic Acid Influence Liver Triacylglycerol and Insulin Resistance in Rats Fed a High-Fructose Diet
by: Gabriela Salim de Castro, et al.
Published: (2015-04-01)

Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish.
by: Browning, L, et al.
Published: (2012)

IMPACT OF DIETARY EICOSAPENTAENOIC AND DOCOSAHEXAENOIC FATTY ACIDS SUPPLEMENTATION ON INFLAMMATORY RESPONSE OF POST CALVING COWS DURING TRANSITION TO LACTATION
by: Shaimaa Elbaz, et al.
Published: (2019-03-01)

Compared with daily, weekly n-3 PUFA intake affects the incorporation of eicosapentaenoic acid and docosahexaenoic acid into platelets and mononuclear cells in humans.
by: Browning, L, et al.
Published: (2014)

Eicosapentaenoic and Docosahexaenoic Acid Supplementation Increases HDL Content in n-3 Fatty Acids and Improves Endothelial Function in Hypertriglyceridemic Patients
by: Paola Peña-de-la-Sancha, et al.
Published: (2023-03-01)

Selective Consumption of Fish Oil at End of the Day Increases the Physiological Fatty Acid Compositions of Eicosapentaenoic Acid and Docosahexaenoic Acid in Mice
by: Hiroki Matsuzaka, et al.
Published: (2022-02-01)

Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid supplementation
by: Angélica Borja-Magno, et al.
Published: (2023-05-01)

Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete against Each Other?
by: Anandita Pal, et al.
Published: (2020-12-01)

Plasma Docosahexaenoic Acid and Eicosapentaenoic Acid Concentrations Are Positively Associated with Brown Adipose Tissue Activity in Humans
by: Angie S. Xiang, et al.
Published: (2020-09-01)

Dietary carbohydrates and fats in nonalcoholic fatty liver disease
by: Yki-Järvinen, H, et al.
Published: (2021)

Comparative Effects of Mineral Oil, Corn Oil, Eicosapentaenoic Acid, and Docosahexaenoic Acid in an In Vitro Atherosclerosis Model
by: Samuel C. R. Sherratt, et al.
Published: (2023-04-01)

Omega-3 Polyunsaturated Fatty Acid Eicosapentaenoic Acid or Docosahexaenoic Acid Improved Ageing-Associated Cognitive Decline by Regulating Glial Polarization
by: Juan Xia, et al.
Published: (2023-07-01)

Role of long-chain polyunsaturated fatty acids, eicosapentaenoic and docosahexaenoic, in the regulation of gene expression during the development of obesity: a systematic review
by: Cristian Sandoval, et al.
Published: (2023-11-01)

In vivo modeling of docosahexaenoic acid and eicosapentaenoic acid-mediated inhibition of both platelet function and accumulation in arterial thrombi
by: Reheman Adili, et al.
Published: (2019-02-01)

Specific effects of gamma-linolenic, eicosapentaenoic, and docosahexaenoic ethyl esters on bone post-ovariectomy in rats.
by: Poulsen, R, et al.
Published: (2007)

Effect of dietary eicosapentaenoic and docosahexaenoic acid on expression of rat liver genes controlling cholesterol homeostasis and on plasma cholesterol level
by: T. Komprda, et al.
Published: (2014-09-01)

Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular events
by: Viet T. Le, et al.
Published: (2023-08-01)

The Effect of Eicosapentaenoic Acid and Docosahexaenoic Acid on Blood Parameters, Production and Composition of Ewe's Milk in Late Pregnancy
by: Hasan Aliarabi, et al.
Published: (2024-02-01)

Influence of Docosahexaenoic and Eicosapentaenoic Acid Ratio and Temperature on the Growth Performance, Fatty Acid Profile, and Liver Morphology of Dusky Grouper (<i>Epinephelus marginatus</i>) (Teleostei: Serranidae) Juveniles
by: Ethiene Fernandes de Oliveira, et al.
Published: (2023-10-01)

Determination of eicosapentaenoic acid and docosahexaenoic acid contents and the oxidation level of fish oil supplements from Bahrain market
by: Hawra Abdulhussain, et al.
Published: (2023-12-01)

Effect of Eicosapentaenoic Acid and Docosahexaenoic Acid on Myogenesis and Mitochondrial Biosynthesis during Murine Skeletal Muscle Cell Differentiation
by: Tun-Yun Hsueh, et al.
Published: (2018-03-01)

Determination of the Relative Efficacy of Eicosapentaenoic Acid and Docosahexaenoic Acid for Anti-Cancer Effects in Human Breast Cancer Models
by: Laura VanderSluis, et al.
Published: (2017-12-01)

Docosahexaenoic Acid and Eicosapentaenoic Acid Intakes Modulate the Association of <i>FADS2</i> Gene Polymorphism rs526126 with Plasma Free Docosahexaenoic Acid Levels in Overweight Children
by: Alexandra Mihailescu, et al.
Published: (2021-10-01)

N-3 Long-Chain Polyunsaturated Fatty Acids, Eicosapentaenoic and Docosahexaenoic Acid, and the Role of Supplementation during Cancer Treatment: A Scoping Review of Current Clinical Evidence
by: Marnie Newell, et al.
Published: (2021-03-01)

Effects of Dietary α-Linolenic Acid Treatment and the Efficiency of Its Conversion to Eicosapentaenoic and Docosahexaenoic Acids in Obesity and Related Diseases
by: Marija Takic, et al.
Published: (2022-07-01)

Assessment of lipid composition and eicosapentaenoic acid/docosahexaenoic acid bioavailability in fish oil obtained through different enrichment methods
by: Rongzhen Song, et al.
Published: (2023-03-01)

Effects of pure eicosapentaenoic and docosahexaenoic acids on oxidative stress, inflammation and body fat mass in patients with type 2 diabetes
by: Fatemeh Azizi-Soleiman, et al.
Published: (2013-01-01)

Regression of Coronary Fatty Plaque and Risk of Cardiac Events According to Blood Pressure Status: Data From a Randomized Trial of Eicosapentaenoic Acid and Docosahexaenoic Acid in Patients With Coronary Artery Disease
by: Francine K. Welty, et al.
Published: (2023-09-01)

Effect of Eicosapentaenoic and Docosahexaenoic Acids Added to Statin Therapy on Coronary Artery Plaque in Patients With Coronary Artery Disease: A Randomized Clinical Trial
by: Abdulhamied Alfaddagh, et al.
Published: (2017-12-01)

Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease
by: Westerbacka, J, et al.
Published: (2010)

Hepatic connexin 32 associates with nonalcoholic fatty liver disease severity
by: Warren, Andrew, et al.
Published: (2020)

Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease.
by: Westerbacka, J, et al.
Published: (2010)